What is sickle cell disease? Learn about this genetic blood disorder, its symptoms, diagnosis, treatment, and recovery options at Liv Hospital.
Send us all your questions or requests, and our expert team will assist you.
Overview and Definition
Sickle cell disease (SCD) is a complex group of inherited blood disorders that affects the structure and function of red blood cells. In a healthy body, red blood cells are flexible and disc-shaped, allowing them to glide easily through even the smallest blood vessels to deliver oxygen to tissues. However, individuals with sickle cell disease possess an abnormal form of hemoglobin, the protein responsible for carrying oxygen. This abnormality causes red blood cells to become rigid, sticky, and shaped like a crescent or “sickle.”
These misshapen cells do not flow easily and often get stuck in small blood vessels, blocking blood flow and oxygen delivery throughout the body. This process leads to intense pain, organ damage, and a high risk of infections. While traditionally managed as a chronic condition, modern advancements in hematology and stem cell transplantation have opened new doors for curative treatments. At Liv Hospital, we combine world-class expertise with cutting-edge technology to help patients move from managing symptoms to seeking a definitive cure.
Sickle cell disease is a lifelong genetic condition characterized by the presence of Hemoglobin S. Hemoglobin is the vital component of red blood cells that binds to oxygen in the lungs and releases it in the tissues. In people with SCD, a genetic mutation causes the hemoglobin molecules to clump together when oxygen levels are low. These clusters distract the red blood cell into a stiff sickle shape.
Unlike normal red blood cells, which live for about 120 days, sickled cells are fragile and break down after only 10 to 20 days. This rapid destruction leads to a constant shortage of red blood cells, a condition known as anemia. Furthermore, the physical shape of these cells causes “vaso-occlusion,” or the blocking of blood vessels, which is the hallmark of the disease’s complications.
As a genetic disorder, the primary risk factor for sickle cell disease is family history. If both parents carry the sickle cell trait, there is a 25% chance with each pregnancy that the child will have the disease. It is most prevalent in populations whose ancestors come from regions where malaria is or was common. This is because carrying a single sickle cell gene provides a survival advantage against malaria.
The disease is most commonly found in people of African descent. However, it also significantly affects those of Hispanic, Southern European (Greek and Italian), Middle Eastern, and Indian heritage. In the United States and globally, newborn screening has become a standard tool to identify the condition early, allowing for intervention before major complications arise.
The impact of sickle cell disease is systemic, meaning it can affect almost every organ system in the body. Because blood flow is essential for life, any interruption caused by sickled cells results in immediate and long-term consequences. The most frequent manifestation is the “sickle cell crisis,” an episode of severe pain that occurs when blood flow is restricted to the bones, chest, or abdomen.
Over time, the repeated lack of oxygen can lead to permanent damage. The spleen, which filters the blood, is often damaged early in childhood, leaving patients more vulnerable to life-threatening infections. Other common complications include:
Understanding the underlying mechanisms of these complications is the first step toward effective management and cure.
Sickle cell disease is not a single disorder but a category of related conditions. The specific type of SCD a person has depends on the genes they inherit from their parents. The most common and severe forms include:
There is also a condition known as Sickle Cell Trait (HbAS). People with the trait inherit only one sickle cell gene and typically do not show symptoms of the disease, but they can pass the gene on to their children.
For decades, treatment for sickle cell disease focused exclusively on managing pain and preventing infections. However, Hematopoietic Stem Cell Transplantation (HSCT), also known as a bone marrow transplant, is currently the only established cure for the condition.
This procedure involves replacing the patient’s bone marrow which produces the sickled cells with healthy stem cells from a donor. When successful, the new stem cells produce healthy, round red blood cells, effectively ending the disease. While historically reserved for children with severe complications, advancements in transplant protocols and donor matching have made this a viable option for a wider range of patients, including adults.
Liv Hospital’s Hematology and Stem Cell Transplant Department is a center of excellence for international patients seeking curative options. We provide a multidisciplinary approach that integrates the expertise of hematologists, transplant surgeons, and pediatric specialists to ensure the highest safety standards.
Our facility in Turkey utilizes state-of-the-art laboratory technology for HLA typing and graft processing. For international patients, Liv Hospital offers coordinated care including pre-arrival consultations, comprehensive evaluation, personalized treatment plans, and ongoing follow-up through telemedicine. Contact Liv Hospital International Patient Services to learn more about sickle cell evaluation and treatment options.
Conditions and Indications
Sickle cell disease manifests through various physical signs that indicate when the body is under stress. These conditions range from mild discomfort to life-threatening emergencies.
The most common indication is the vaso-occlusive crisis. This occurs when sickled cells block the capillary beds, leading to tissue ischemia. Patients often report:
Indications for emergency care include sudden neurological changes (indicating a stroke risk), a fever over 101°F (38.5°C), or sudden difficulty breathing. Early recognition of these indications can prevent permanent organ damage.
Diagnosis and Evaluation
Confirming sickle cell disease and evaluating the extent of its impact requires a series of specialized medical tests.
Diagnosis usually begins with a simple blood test. At Liv Hospital, we use:
Before starting treatment, a comprehensive evaluation of the heart, lungs, and kidneys is performed to ensure the patient can safely undergo intensive therapies like stem cell transplantation.
Treatment and Procedures
Treatment for sickle cell disease has evolved from simple pain management to advanced curative procedures.
Treatment is typically divided into management and curative paths:
The procedure involves “conditioning” where the patient’s bone marrow is cleared, followed by the infusion of healthy stem cells. These cells then “engraft” and begin producing healthy red blood cells.
Recovery and Follow-up
The recovery phase is crucial for ensuring that the treatment, particularly a transplant, is successful over the long term.
After a stem cell transplant, patients spend several weeks in a specialized, sterile unit to prevent infection. The “recovery” phase continues at home for several months as the new immune system grows stronger.
Follow-up care includes monitoring for Graft versus host disease (GvHD) and ensuring that the new blood cells are functioning correctly. Regular blood tests and organ screenings are part of the lifelong wellness plan at Liv Hospital.
Send us all your questions or requests, and our expert team will assist you.
No, sickle cell disease is a genetic condition. You are born with it, and you cannot “catch” it from someone else or spread it like a virus.
With modern medical care, many people with SCD live into their 40s, 50s, or longer. However, a successful stem cell transplant can significantly improve both the quality of life and life expectancy by curing the disorder.
Yes. While transplants were once limited to children, new “reduced-intensity” conditioning protocols allow many adults to safely undergo the procedure at specialized centers like Liv Hospital.
A crisis is a period of intense pain caused by sickle cells blocking blood flow. It often requires hospitalization for hydration and strong pain management.
People with the trait have only one mutated gene and usually do not have symptoms. Those with the disease have two mutated genes and experience the full range of complications.
Your Comparison List (you must select at least 2 packages)
